Daniel T Dibaba1,2, Kemi Ogunsina3, Dejana Braithwaite4, Tomi Akinyemiju5,6,7. 1. Department of Epidemiology, University of Kentucky, Lexington, KY, USA. 2. Markey Cancer Center, University of Kentucky, Lexington, KY, USA. 3. Department of Public Health Sciences, University of Miami, Miami, FL, USA. 4. Department of Oncology, Georgetown University, Washington, DC, USA. 5. Department of Epidemiology, University of Kentucky, Lexington, KY, USA. tomiakin@uky.edu. 6. Markey Cancer Center, University of Kentucky, Lexington, KY, USA. tomiakin@uky.edu. 7. College of Public Health and Markey Cancer Center, University of Kentucky, Lexington, KY, USA. tomiakin@uky.edu.
Abstract
PURPOSE: To investigate the association between metabolic syndrome (MetS) and risk of breast cancer mortality by menopausal status, obesity, and subtype. METHODS: Data from 94,555 women free of cancer at baseline in the National Institute of Health-American Association of Retired Persons Diet and Health Study cohort (NIH-AARP) were used to investigate the prospective associations of baseline MetS and components with risk of breast cancer mortality using Cox proportional hazard regression models adjusted for baseline behavioral and demographic covariates. RESULTS: During a mean follow-up duration of 14 years, 607 women in the cohort died of breast cancer. Overall, MetS was associated with a 73% increased risk of breast cancer mortality (HR 1.73; 95% CI 1.09-2.75); the association remained significant among post-menopausal women overall (HR 2.07, 95% CI 1.32, 3.25), and among those with overweight/obesity (HR 1.15, 95% CI 0.81, 1.64). MetS was associated with increased risk of breast cancer mortality for ER+/PR+ (HR 1.28, 95% CI 0.52, 3.16) and lower risk for ER-/PR- (HR 0.44, 95% CI 0.11, 1.75) subtypes; however, the associations were not statistically significant. Of the individual MetS components, high waist circumference (HR 1.32, 95% CI 1.03, 1.70), high cholesterol (HR 1.24, 95% CI 1.05, 1.46), and hypertension (HR 1.24, 95% CI 1.05, 1.46) were independently associated with increased risk of breast cancer mortality. CONCLUSIONS: MetS was associated with increased risk of breast cancer mortality, especially among post-menopausal women. Further studies with larger sample sizes are needed to definitively determine the extent to which these associations vary by breast cancer subtype.
PURPOSE: To investigate the association between metabolic syndrome (MetS) and risk of breast cancer mortality by menopausal status, obesity, and subtype. METHODS: Data from 94,555 women free of cancer at baseline in the National Institute of Health-American Association of Retired Persons Diet and Health Study cohort (NIH-AARP) were used to investigate the prospective associations of baseline MetS and components with risk of breast cancer mortality using Cox proportional hazard regression models adjusted for baseline behavioral and demographic covariates. RESULTS: During a mean follow-up duration of 14 years, 607 women in the cohort died of breast cancer. Overall, MetS was associated with a 73% increased risk of breast cancer mortality (HR 1.73; 95% CI 1.09-2.75); the association remained significant among post-menopausal women overall (HR 2.07, 95% CI 1.32, 3.25), and among those with overweight/obesity (HR 1.15, 95% CI 0.81, 1.64). MetS was associated with increased risk of breast cancer mortality for ER+/PR+ (HR 1.28, 95% CI 0.52, 3.16) and lower risk for ER-/PR- (HR 0.44, 95% CI 0.11, 1.75) subtypes; however, the associations were not statistically significant. Of the individual MetS components, high waist circumference (HR 1.32, 95% CI 1.03, 1.70), high cholesterol (HR 1.24, 95% CI 1.05, 1.46), and hypertension (HR 1.24, 95% CI 1.05, 1.46) were independently associated with increased risk of breast cancer mortality. CONCLUSIONS:MetS was associated with increased risk of breast cancer mortality, especially among post-menopausal women. Further studies with larger sample sizes are needed to definitively determine the extent to which these associations vary by breast cancer subtype.
Entities:
Keywords:
Breast cancer mortality; Hormone-receptor subtypes; Menopause; Metabolic syndrome; Obesity
Authors: A Schatzkin; A F Subar; F E Thompson; L C Harlan; J Tangrea; A R Hollenbeck; P E Hurwitz; L Coyle; N Schussler; D S Michaud; L S Freedman; C C Brown; D Midthune; V Kipnis Journal: Am J Epidemiol Date: 2001-12-15 Impact factor: 4.897
Authors: Page E Abrahamson; Marilie D Gammon; Mary Jo Lund; Elaine W Flagg; Peggy L Porter; June Stevens; Christine A Swanson; Louise A Brinton; J William Eley; Ralph J Coates Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-10 Impact factor: 4.254
Authors: Vasilios G Athyros; Emmanuel S Ganotakis; Moses S Elisaf; Evangelos N Liberopoulos; Ioannis A Goudevenos; Asterios Karagiannis Journal: Int J Cardiol Date: 2006-07-18 Impact factor: 4.164
Authors: Marilyn J Borugian; Samuel B Sheps; Charmaine Kim-Sing; Ivo A Olivotto; Cheri Van Patten; Bruce P Dunn; Andrew J Coldman; John D Potter; Richard P Gallagher; T Gregory Hislop Journal: Am J Epidemiol Date: 2003-11-15 Impact factor: 4.897
Authors: Mengting Chen; Yang Zhao; Xueli Yang; Yuanyuan Zhao; Qiqi Liu; Yang Liu; Yifeng Hou; Hefen Sun; Wei Jin Journal: Breast Cancer Res Treat Date: 2021-04-16 Impact factor: 4.872
Authors: Rachel A Sabol; Vidal A Villela; Alexandra Denys; Benjamin T Freeman; Alifiani B Hartono; Rachel M Wise; Mark A A Harrison; Maxwell B Sandler; Fokhrul Hossain; Lucio Miele; Bruce A Bunnell Journal: Int J Mol Sci Date: 2020-04-15 Impact factor: 5.923
Authors: Trygve Lofterød; Hanne Frydenberg; Vidar Flote; Anne Elise Eggen; Anne McTiernan; Elin S Mortensen; Lars A Akslen; Jon B Reitan; Tom Wilsgaard; Inger Thune Journal: Breast Cancer Res Treat Date: 2020-05-20 Impact factor: 4.872
Authors: Emily J Gallagher; Kezhen Fei; Sheldon M Feldman; Elisa Port; Neil B Friedman; Susan K Boolbol; Brigid Killelea; Melissa Pilewskie; Lydia Choi; Tari King; Anupma Nayak; Rebeca Franco; Daliz Cruz; Irini M Antoniou; Derek LeRoith; Nina A Bickell Journal: Breast Cancer Res Date: 2020-05-12 Impact factor: 6.466